microRNA information: hsa-miR-130a-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-130a-3p | miRbase |
| Accession: | MIMAT0000425 | miRbase |
| Precursor name: | hsa-mir-130a | miRbase |
| Precursor accession: | MI0000448 | miRbase |
| Symbol: | MIR130A | HGNC |
| RefSeq ID: | NR_029673 | GenBank |
| Sequence: | CAGUGCAAUGUUAAAAGGGCAU |
Reported expression in cancers: hsa-miR-130a-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-130a-3p | bladder cancer | upregulation | "We focused on the miR-130 family miR-130b miR-301a ......" | 26837847 | |
| hsa-miR-130a-3p | breast cancer | downregulation | "In this study we conducted miRNAs profile comparis ......" | 24788655 | Microarray; qPCR |
| hsa-miR-130a-3p | breast cancer | downregulation | "MiR-130a has been demonstrated to play important r ......" | 25755726 | |
| hsa-miR-130a-3p | esophageal cancer | deregulation | "The expression profiles of miRNAs in paired EC and ......" | 23761828 | Microarray; qPCR |
| hsa-miR-130a-3p | gastric cancer | upregulation | "The high expression of miR-20a miR-25 miR-93 miR-1 ......" | 22996433 | |
| hsa-miR-130a-3p | head and neck cancer | deregulation | "Real-time polymerase chain reaction PCR analysis c ......" | 21560177 | qPCR |
| hsa-miR-130a-3p | liver cancer | downregulation | "MicroRNA 130a is down regulated in hepatocellular ......" | 25218269 | qPCR |
| hsa-miR-130a-3p | lung cancer | deregulation | "Microarray studies revealed alterations in the exp ......" | 19748927 | Microarray; Reverse transcription PCR |
| hsa-miR-130a-3p | lung squamous cell cancer | downregulation | "miR 130a regulates macrophage polarization and is ......" | 26398698 | qPCR |
| hsa-miR-130a-3p | melanoma | downregulation | "Among the miRNAs that were commonly and significan ......" | 27149382 | |
| hsa-miR-130a-3p | prostate cancer | downregulation | "MiR 130a miR 203 and miR 205 jointly repress key o ......" | 22391564 | |
| hsa-miR-130a-3p | prostate cancer | downregulation | "Microarray analysis of mRNA expression was also co ......" | 26074357 | Microarray |
| hsa-miR-130a-3p | thyroid cancer | deregulation | "Deregulated miRNAs were confirmed by quantitative ......" | 24127332 | qPCR; in situ hybridization |
Reported cancer pathway affected by hsa-miR-130a-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-130a-3p | chronic myeloid leukemia | Apoptosis pathway | "Functional studies of miR 130a on the inhibitory p ......" | 26494558 | Western blot; Luciferase |
| hsa-miR-130a-3p | gastric cancer | Apoptosis pathway | "Targeting of RUNX3 by miR 130a and miR 495 coopera ......" | 26375442 | Luciferase |
| hsa-miR-130a-3p | lung squamous cell cancer | Apoptosis pathway | "MiR 130a overcomes gefitinib resistance by targeti ......" | 24606471 | |
| hsa-miR-130a-3p | ovarian cancer | Apoptosis pathway | "Downregulation of miR 130a contributes to cisplati ......" | 24145606 | Flow cytometry; MTT assay |
| hsa-miR-130a-3p | ovarian cancer | PI3K/Akt signaling pathway; Apoptosis pathway | "Expression of MiR 130a in Serum Samples of Patient ......" | 27062783 | |
| hsa-miR-130a-3p | sarcoma | Epithelial mesenchymal transition pathway | "MicroRNA 130a promotes the metastasis and epitheli ......" | 27035216 |
Reported cancer prognosis affected by hsa-miR-130a-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-130a-3p | B cell lymphoma | drug resistance; progression; recurrence | "Circulating microRNA 125b and microRNA 130a expres ......" | 26870228 | |
| hsa-miR-130a-3p | bladder cancer | malignant trasformation | "We screened 723 miRNAs by microarray and selected ......" | 23945108 | |
| hsa-miR-130a-3p | bladder cancer | staging; progression | "Formalin-fixed paraffin-embedded samples of 44 Ta ......" | 24439061 | |
| hsa-miR-130a-3p | bladder cancer | cell migration; malignant trasformation; progression | "The miR 130 family promotes cell migration and inv ......" | 26837847 | |
| hsa-miR-130a-3p | breast cancer | drug resistance | "The drug resistance of MCF-7/ADR cells was evaluat ......" | 18971180 | Flow cytometry; MTT assay |
| hsa-miR-130a-3p | breast cancer | metastasis; progression | "Aberrant plasma levels of circulating miR 16 miR 1 ......" | 26033453 | |
| hsa-miR-130a-3p | breast cancer | worse prognosis; drug resistance | "The aim of this study was to investigate the role ......" | 27746365 | |
| hsa-miR-130a-3p | cervical and endocervical cancer | poor survival | "Prognostic significance of low DICER expression re ......" | 24787017 | Luciferase |
| hsa-miR-130a-3p | chronic myeloid leukemia | drug resistance; poor survival; worse prognosis | "Functional studies of miR 130a on the inhibitory p ......" | 26494558 | Western blot; Luciferase |
| hsa-miR-130a-3p | gastric cancer | metastasis; poor survival | "The high expression of miR-20a miR-25 miR-93 miR-1 ......" | 22996433 | |
| hsa-miR-130a-3p | gastric cancer | tumorigenesis; worse prognosis | "miR 130a acts as a potential diagnostic biomarker ......" | 26134263 | Luciferase; Transwell assay |
| hsa-miR-130a-3p | gastric cancer | progression | "Targeting of RUNX3 by miR 130a and miR 495 coopera ......" | 26375442 | Luciferase |
| hsa-miR-130a-3p | glioblastoma | poor survival; recurrence | "Moreover miR-326 miR-130a miR-155 miR-210 and 4 mi ......" | 23302469 | |
| hsa-miR-130a-3p | glioblastoma | drug resistance | "miR 130a can predict response to temozolomide in p ......" | 25890369 | |
| hsa-miR-130a-3p | liver cancer | worse prognosis; staging; metastasis; tumor size; poor survival | "MicroRNA 130a is down regulated in hepatocellular ......" | 25218269 | |
| hsa-miR-130a-3p | liver cancer | progression | "This study investigated the potential of serum mic ......" | 26352740 | |
| hsa-miR-130a-3p | lung squamous cell cancer | drug resistance | "MiR 130a overcomes gefitinib resistance by targeti ......" | 24606471 | |
| hsa-miR-130a-3p | lung squamous cell cancer | worse prognosis; drug resistance; staging; metastasis | "miR 130a regulates macrophage polarization and is ......" | 26398698 | Western blot; Luciferase |
| hsa-miR-130a-3p | ovarian cancer | drug resistance | "High-throughput analysis of the miRNA profile in a ......" | 18823650 | |
| hsa-miR-130a-3p | ovarian cancer | drug resistance | "Furthermore we discuss several other microRNAs tha ......" | 20083225 | |
| hsa-miR-130a-3p | ovarian cancer | drug resistance | "Expression of miR 130a in cisplatin resistant cell ......" | 22455133 | MTT assay |
| hsa-miR-130a-3p | ovarian cancer | drug resistance | "Altered microRNA expression in cisplatin resistant ......" | 22614869 | Western blot; MTT assay |
| hsa-miR-130a-3p | ovarian cancer | drug resistance | "Downregulation of miR 130a contributes to cisplati ......" | 24145606 | Flow cytometry; MTT assay |
| hsa-miR-130a-3p | ovarian cancer | drug resistance | "Regulatory effects and associated mechanisms of mi ......" | 24490491 | MTT assay; Western blot |
| hsa-miR-130a-3p | ovarian cancer | drug resistance | "MiR 130a and MiR 374a Function as Novel Regulators ......" | 26043084 | Western blot |
| hsa-miR-130a-3p | ovarian cancer | drug resistance | "NRP1 is targeted by miR 130a and miR 130b and is a ......" | 26573160 | |
| hsa-miR-130a-3p | ovarian cancer | drug resistance; metastasis | "Expression of MiR 130a in Serum Samples of Patient ......" | 27062783 | |
| hsa-miR-130a-3p | prostate cancer | drug resistance | "miR 130a activates apoptotic signaling through act ......" | 26074357 | Luciferase |
| hsa-miR-130a-3p | sarcoma | metastasis; worse prognosis | "MicroRNA 130a promotes the metastasis and epitheli ......" | 27035216 |
Reported gene related to hsa-miR-130a-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-130a-3p | bladder cancer | PTEN | "The miR 130 family promotes cell migration and inv ......" | 26837847 |
| hsa-miR-130a-3p | cervical and endocervical cancer | PTEN | "In addition by targeting PTEN 3' untranslated regi ......" | 27040383 |
| hsa-miR-130a-3p | ovarian cancer | PTEN | "Down-regulated miR-130a did not affect cell prolif ......" | 24490491 |
| hsa-miR-130a-3p | ovarian cancer | PTEN | "Platinum-resistant patients had significantly high ......" | 27062783 |
| hsa-miR-130a-3p | ovarian cancer | PTEN | "We found that miR-130a was upregulated in SKOV3/CI ......" | 22614869 |
| hsa-miR-130a-3p | ovarian cancer | PTEN | "This role of miR-130a may be achieved by regulatin ......" | 26043084 |
| hsa-miR-130a-3p | sarcoma | PTEN | "MicroRNA 130a promotes the metastasis and epitheli ......" | 27035216 |
| hsa-miR-130a-3p | ovarian cancer | ABCB1 | "Over-expressions of miR-130a had no effect on cell ......" | 24490491 |
| hsa-miR-130a-3p | ovarian cancer | ABCB1 | "Moreover downregulation of miR-130a could inhibit ......" | 22614869 |
| hsa-miR-130a-3p | gastric cancer | RUNX3 | "miR 130a acts as a potential diagnostic biomarker ......" | 26134263 |
| hsa-miR-130a-3p | gastric cancer | RUNX3 | "Targeting of RUNX3 by miR 130a and miR 495 coopera ......" | 26375442 |
| hsa-miR-130a-3p | ovarian cancer | ABCB6 | "Moreover downregulation of miR-130a could inhibit ......" | 22614869 |
| hsa-miR-130a-3p | cervical and endocervical cancer | AKT1 | "In addition by targeting PTEN 3' untranslated regi ......" | 27040383 |
| hsa-miR-130a-3p | glioblastoma | APEX1 | "GSEA and GO analysis indicated that lower miR-130a ......" | 25890369 |
| hsa-miR-130a-3p | ovarian cancer | BCL2 | "Platinum-resistant patients had significantly high ......" | 27062783 |
| hsa-miR-130a-3p | gastric cancer | BCL2L11 | "Combination of miR-130a and miR-495 significantly ......" | 26375442 |
| hsa-miR-130a-3p | prostate cancer | CASP8 | "miR 130a activates apoptotic signaling through act ......" | 26074357 |
| hsa-miR-130a-3p | ovarian cancer | CSF1 | "Finally downstream target validation was proven fo ......" | 18823650 |
| hsa-miR-130a-3p | B cell lymphoma | DDIT3 | "Circulating microRNA 125b and microRNA 130a expres ......" | 26870228 |
| hsa-miR-130a-3p | cervical and endocervical cancer | DICER1 | "Prognostic significance of low DICER expression re ......" | 24787017 |
| hsa-miR-130a-3p | glioblastoma | IGKV1D-35 | "miR 130a can predict response to temozolomide in p ......" | 25890369 |
| hsa-miR-130a-3p | glioblastoma | MGMT | "miR 130a can predict response to temozolomide in p ......" | 25890369 |
| hsa-miR-130a-3p | cervical and endocervical cancer | NFASC | "NF κB modulated miR 130a targets TNF α in cervic ......" | 24885472 |
| hsa-miR-130a-3p | ovarian cancer | NOL3 | "MTT assay and flow cytometry FCM results showed th ......" | 24145606 |
| hsa-miR-130a-3p | ovarian cancer | NRP1 | "NRP1 is targeted by miR 130a and miR 130b and is a ......" | 26573160 |
| hsa-miR-130a-3p | bladder cancer | PTK2 | "The miR 130 family promotes cell migration and inv ......" | 26837847 |
| hsa-miR-130a-3p | breast cancer | RAB5A | "MicroRNA 130a inhibits cell proliferation invasion ......" | 25755726 |
| hsa-miR-130a-3p | prostate cancer | SLAIN1 | "Based on mRNA microarray analysis and luciferase r ......" | 26074357 |
| hsa-miR-130a-3p | ovarian cancer | TECRL | "Altered microRNA expression in cisplatin resistant ......" | 22614869 |
| hsa-miR-130a-3p | cervical and endocervical cancer | TNF | "NF κB modulated miR 130a targets TNF α in cervic ......" | 24885472 |
| hsa-miR-130a-3p | chronic myeloid leukemia | TP53 | "We in this study aimed to investigate the function ......" | 26494558 |
| hsa-miR-130a-3p | ovarian cancer | XIAP | "Downregulation of miR 130a contributes to cisplati ......" | 24145606 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-130a-3p | DNM2 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUSC; SARC; THCA | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.089; TCGA BRCA -0.078; TCGA CESC -0.082; TCGA ESCA -0.293; TCGA HNSC -0.075; TCGA KIRC -0.071; TCGA LIHC -0.097; TCGA LUSC -0.07; TCGA SARC -0.085; TCGA THCA -0.053 |
hsa-miR-130a-3p | RAB5A | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; PRAD; STAD; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BLCA -0.072; TCGA COAD -0.059; TCGA ESCA -0.131; TCGA HNSC -0.08; TCGA KIRP -0.092; TCGA LUAD -0.073; TCGA PRAD -0.125; TCGA STAD -0.073; TCGA UCEC -0.078 |
hsa-miR-130a-3p | KIAA1468 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRC; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.074; TCGA CESC -0.153; TCGA COAD -0.159; TCGA HNSC -0.142; TCGA KIRC -0.066; TCGA OV -0.11; TCGA PRAD -0.163; TCGA SARC -0.111; TCGA STAD -0.164; TCGA UCEC -0.101 |
hsa-miR-130a-3p | CMPK1 | 13 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.058; TCGA CESC -0.149; TCGA ESCA -0.401; TCGA HNSC -0.058; TCGA KIRP -0.141; TCGA LUAD -0.135; TCGA LUSC -0.069; TCGA OV -0.141; TCGA PRAD -0.143; TCGA SARC -0.138; TCGA THCA -0.064; TCGA STAD -0.153; TCGA UCEC -0.204 |
hsa-miR-130a-3p | KLHL20 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUSC; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.072; TCGA CESC -0.112; TCGA COAD -0.092; TCGA HNSC -0.122; TCGA KIRP -0.193; TCGA LIHC -0.072; TCGA LUSC -0.079; TCGA PRAD -0.111; TCGA SARC -0.11; TCGA THCA -0.053; TCGA STAD -0.053 |
hsa-miR-130a-3p | BBX | 9 cancers: BLCA; COAD; HNSC; KIRP; LUAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.076; TCGA COAD -0.121; TCGA HNSC -0.134; TCGA KIRP -0.121; TCGA LUAD -0.055; TCGA PRAD -0.148; TCGA SARC -0.072; TCGA STAD -0.127; TCGA UCEC -0.092 |
hsa-miR-130a-3p | SKP1 | 10 cancers: BLCA; BRCA; COAD; KIRP; LGG; LIHC; LUAD; OV; PAAD; SARC | MirTarget | TCGA BLCA -0.087; TCGA BRCA -0.14; TCGA COAD -0.109; TCGA KIRP -0.117; TCGA LGG -0.072; TCGA LIHC -0.072; TCGA LUAD -0.083; TCGA OV -0.085; TCGA PAAD -0.146; TCGA SARC -0.054 |
hsa-miR-130a-3p | SH3D19 | 10 cancers: BLCA; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.251; TCGA ESCA -0.241; TCGA HNSC -0.203; TCGA KIRP -0.121; TCGA LUAD -0.16; TCGA LUSC -0.111; TCGA PRAD -0.06; TCGA SARC -0.193; TCGA THCA -0.067; TCGA STAD -0.107 |
hsa-miR-130a-3p | RNF145 | 9 cancers: BLCA; COAD; KIRC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.078; TCGA COAD -0.168; TCGA KIRC -0.182; TCGA LUAD -0.174; TCGA LUSC -0.098; TCGA PRAD -0.075; TCGA THCA -0.119; TCGA STAD -0.088; TCGA UCEC -0.096 |
hsa-miR-130a-3p | VPS37A | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.131; TCGA BRCA -0.085; TCGA CESC -0.075; TCGA COAD -0.135; TCGA HNSC -0.057; TCGA KIRP -0.195; TCGA LUAD -0.187; TCGA LUSC -0.07; TCGA OV -0.099; TCGA PRAD -0.067; TCGA SARC -0.16; TCGA THCA -0.09; TCGA STAD -0.142; TCGA UCEC -0.146 |
hsa-miR-130a-3p | HBP1 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC | MirTarget; miRNATAP | TCGA BLCA -0.074; TCGA CESC -0.105; TCGA COAD -0.07; TCGA HNSC -0.158; TCGA KIRC -0.059; TCGA KIRP -0.099; TCGA LUAD -0.107; TCGA PAAD -0.089; TCGA PRAD -0.093; TCGA SARC -0.079 |
hsa-miR-130a-3p | WDR47 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.11; TCGA CESC -0.134; TCGA COAD -0.126; TCGA HNSC -0.111; TCGA KIRP -0.171; TCGA LUAD -0.056; TCGA LUSC -0.15; TCGA PRAD -0.082; TCGA SARC -0.139; TCGA STAD -0.145 |
hsa-miR-130a-3p | UBXN2B | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PRAD; STAD | MirTarget | TCGA BLCA -0.058; TCGA CESC -0.095; TCGA COAD -0.119; TCGA ESCA -0.114; TCGA HNSC -0.077; TCGA KIRP -0.149; TCGA LIHC -0.106; TCGA LUAD -0.113; TCGA PRAD -0.145; TCGA STAD -0.154 |
hsa-miR-130a-3p | HCFC2 | 11 cancers: BLCA; COAD; HNSC; KIRP; LGG; LUAD; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.101; TCGA COAD -0.157; TCGA HNSC -0.097; TCGA KIRP -0.184; TCGA LGG -0.063; TCGA LUAD -0.103; TCGA OV -0.078; TCGA PRAD -0.094; TCGA SARC -0.092; TCGA STAD -0.108; TCGA UCEC -0.068 |
hsa-miR-130a-3p | AFF1 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.137; TCGA BRCA -0.057; TCGA COAD -0.068; TCGA ESCA -0.107; TCGA HNSC -0.197; TCGA KIRC -0.13; TCGA LUAD -0.075; TCGA PRAD -0.178; TCGA SARC -0.187; TCGA UCEC -0.118 |
hsa-miR-130a-3p | RPS6KA5 | 9 cancers: BLCA; CESC; COAD; HNSC; LGG; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.239; TCGA CESC -0.227; TCGA COAD -0.187; TCGA HNSC -0.205; TCGA LGG -0.141; TCGA PRAD -0.241; TCGA SARC -0.31; TCGA STAD -0.123; TCGA UCEC -0.3 |
hsa-miR-130a-3p | HADHB | 11 cancers: BLCA; COAD; HNSC; KIRP; LGG; LUAD; OV; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.105; TCGA COAD -0.072; TCGA HNSC -0.051; TCGA KIRP -0.198; TCGA LGG -0.16; TCGA LUAD -0.082; TCGA OV -0.07; TCGA PAAD -0.091; TCGA PRAD -0.132; TCGA THCA -0.224; TCGA UCEC -0.104 |
hsa-miR-130a-3p | LONRF3 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.202; TCGA COAD -0.194; TCGA ESCA -1.045; TCGA HNSC -0.362; TCGA KIRC -0.144; TCGA KIRP -0.291; TCGA LGG -0.157; TCGA LIHC -0.151; TCGA LUAD -0.292; TCGA SARC -0.167; TCGA STAD -0.164; TCGA UCEC -0.215 |
hsa-miR-130a-3p | CPEB3 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.217; TCGA BRCA -0.057; TCGA CESC -0.184; TCGA COAD -0.097; TCGA ESCA -0.232; TCGA HNSC -0.252; TCGA LGG -0.182; TCGA LUAD -0.121; TCGA PRAD -0.166; TCGA STAD -0.122; TCGA UCEC -0.177 |
hsa-miR-130a-3p | APPL1 | 9 cancers: BLCA; ESCA; HNSC; KIRP; LUAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.06; TCGA ESCA -0.117; TCGA HNSC -0.183; TCGA KIRP -0.084; TCGA LUAD -0.102; TCGA PRAD -0.167; TCGA THCA -0.081; TCGA STAD -0.161; TCGA UCEC -0.08 |
hsa-miR-130a-3p | FBXO28 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.061; TCGA BRCA -0.059; TCGA CESC -0.069; TCGA COAD -0.127; TCGA HNSC -0.093; TCGA KIRP -0.107; TCGA LUAD -0.075; TCGA PRAD -0.179; TCGA SARC -0.111; TCGA STAD -0.16; TCGA UCEC -0.11 |
hsa-miR-130a-3p | LNPEP | 13 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.122; TCGA CESC -0.111; TCGA COAD -0.26; TCGA HNSC -0.414; TCGA KIRP -0.235; TCGA LIHC -0.104; TCGA LUAD -0.166; TCGA LUSC -0.19; TCGA OV -0.123; TCGA PRAD -0.307; TCGA SARC -0.245; TCGA THCA -0.187; TCGA STAD -0.134 |
hsa-miR-130a-3p | SNX27 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.106; TCGA BRCA -0.071; TCGA CESC -0.065; TCGA HNSC -0.111; TCGA KIRP -0.132; TCGA LIHC -0.189; TCGA LUAD -0.101; TCGA PRAD -0.121; TCGA SARC -0.079; TCGA THCA -0.208; TCGA STAD -0.102; TCGA UCEC -0.072 |
hsa-miR-130a-3p | MARCH2 | 11 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; LUSC; OV; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.11; TCGA BRCA -0.092; TCGA CESC -0.135; TCGA HNSC -0.147; TCGA LIHC -0.101; TCGA LUAD -0.051; TCGA LUSC -0.136; TCGA OV -0.101; TCGA SARC -0.22; TCGA THCA -0.067; TCGA UCEC -0.094 |
hsa-miR-130a-3p | EFR3A | 14 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.125; TCGA BRCA -0.084; TCGA COAD -0.082; TCGA HNSC -0.108; TCGA KIRP -0.108; TCGA LIHC -0.118; TCGA LUAD -0.14; TCGA LUSC -0.176; TCGA OV -0.208; TCGA PRAD -0.207; TCGA SARC -0.154; TCGA THCA -0.09; TCGA STAD -0.094; TCGA UCEC -0.099 |
hsa-miR-130a-3p | CLTC | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.053; TCGA BRCA -0.16; TCGA COAD -0.07; TCGA ESCA -0.147; TCGA HNSC -0.138; TCGA KIRP -0.307; TCGA LIHC -0.139; TCGA LUAD -0.115; TCGA LUSC -0.106; TCGA OV -0.063; TCGA PAAD -0.19; TCGA PRAD -0.224; TCGA THCA -0.214; TCGA STAD -0.084; TCGA UCEC -0.092 |
hsa-miR-130a-3p | CLIP1 | 10 cancers: BLCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.171; TCGA HNSC -0.174; TCGA KIRP -0.206; TCGA LUAD -0.148; TCGA LUSC -0.101; TCGA PRAD -0.154; TCGA SARC -0.309; TCGA THCA -0.185; TCGA STAD -0.118; TCGA UCEC -0.127 |
hsa-miR-130a-3p | MBNL3 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; PRAD; THCA; STAD | MirTarget; mirMAP; miRNATAP | TCGA BLCA -0.315; TCGA COAD -0.273; TCGA ESCA -0.27; TCGA HNSC -0.614; TCGA KIRP -0.289; TCGA LUAD -0.167; TCGA PRAD -0.329; TCGA THCA -0.235; TCGA STAD -0.166 |
hsa-miR-130a-3p | PPP1R15B | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.09; TCGA COAD -0.078; TCGA ESCA -0.133; TCGA HNSC -0.116; TCGA KIRC -0.087; TCGA KIRP -0.138; TCGA PRAD -0.186; TCGA STAD -0.13; TCGA UCEC -0.067 |
hsa-miR-130a-3p | TOM1L1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.068; TCGA BRCA -0.213; TCGA COAD -0.122; TCGA ESCA -0.299; TCGA HNSC -0.09; TCGA KIRP -0.232; TCGA LIHC -0.134; TCGA LUAD -0.226; TCGA PAAD -0.291; TCGA PRAD -0.247; TCGA THCA -0.108; TCGA STAD -0.132; TCGA UCEC -0.19 |
hsa-miR-130a-3p | ARHGAP1 | 9 cancers: BLCA; BRCA; HNSC; LUAD; LUSC; OV; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.155; TCGA BRCA -0.054; TCGA HNSC -0.11; TCGA LUAD -0.087; TCGA LUSC -0.069; TCGA OV -0.068; TCGA SARC -0.243; TCGA THCA -0.078; TCGA UCEC -0.112 |
hsa-miR-130a-3p | KIAA1191 | 10 cancers: BLCA; COAD; HNSC; KIRP; LUAD; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.075; TCGA COAD -0.071; TCGA HNSC -0.059; TCGA KIRP -0.151; TCGA LUAD -0.08; TCGA OV -0.076; TCGA PAAD -0.184; TCGA SARC -0.168; TCGA STAD -0.12; TCGA UCEC -0.05 |
hsa-miR-130a-3p | FAM20B | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.084; TCGA BRCA -0.066; TCGA CESC -0.097; TCGA COAD -0.081; TCGA HNSC -0.105; TCGA LIHC -0.173; TCGA LUAD -0.056; TCGA LUSC -0.088; TCGA PAAD -0.178; TCGA PRAD -0.071; TCGA SARC -0.115; TCGA STAD -0.179; TCGA UCEC -0.057 |
hsa-miR-130a-3p | PXK | 10 cancers: BLCA; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.146; TCGA ESCA -0.139; TCGA HNSC -0.287; TCGA KIRP -0.349; TCGA LUAD -0.132; TCGA LUSC -0.185; TCGA OV -0.11; TCGA PRAD -0.163; TCGA SARC -0.156; TCGA THCA -0.104 |
hsa-miR-130a-3p | TRIM23 | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PRAD; SARC | MirTarget | TCGA BLCA -0.106; TCGA BRCA -0.06; TCGA HNSC -0.109; TCGA KIRC -0.116; TCGA KIRP -0.133; TCGA LGG -0.095; TCGA LIHC -0.052; TCGA LUAD -0.081; TCGA PRAD -0.104; TCGA SARC -0.066 |
hsa-miR-130a-3p | ELL2 | 10 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; OV; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.149; TCGA BRCA -0.067; TCGA COAD -0.11; TCGA HNSC -0.096; TCGA LUAD -0.149; TCGA LUSC -0.143; TCGA OV -0.368; TCGA PRAD -0.132; TCGA SARC -0.316; TCGA UCEC -0.284 |
hsa-miR-130a-3p | FBXW11 | 15 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.093; TCGA CESC -0.069; TCGA COAD -0.088; TCGA HNSC -0.15; TCGA KIRC -0.077; TCGA KIRP -0.22; TCGA LGG -0.07; TCGA LIHC -0.06; TCGA LUAD -0.089; TCGA LUSC -0.079; TCGA PAAD -0.123; TCGA PRAD -0.158; TCGA SARC -0.068; TCGA THCA -0.15; TCGA STAD -0.093 |
hsa-miR-130a-3p | NPTN | 12 cancers: BLCA; BRCA; COAD; KIRP; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.155; TCGA BRCA -0.065; TCGA COAD -0.124; TCGA KIRP -0.127; TCGA LIHC -0.063; TCGA LUAD -0.094; TCGA LUSC -0.072; TCGA OV -0.081; TCGA PAAD -0.124; TCGA SARC -0.234; TCGA STAD -0.071; TCGA UCEC -0.12 |
hsa-miR-130a-3p | SACM1L | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.091; TCGA COAD -0.099; TCGA ESCA -0.129; TCGA HNSC -0.062; TCGA KIRP -0.095; TCGA LUAD -0.07; TCGA PRAD -0.149; TCGA STAD -0.105; TCGA UCEC -0.09 |
hsa-miR-130a-3p | CCDC6 | 9 cancers: BLCA; ESCA; HNSC; KIRP; LUAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.127; TCGA ESCA -0.173; TCGA HNSC -0.123; TCGA KIRP -0.099; TCGA LUAD -0.075; TCGA PRAD -0.231; TCGA SARC -0.243; TCGA THCA -0.114; TCGA STAD -0.232 |
hsa-miR-130a-3p | SBNO1 | 10 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget; mirMAP; miRNATAP | TCGA BLCA -0.127; TCGA COAD -0.203; TCGA HNSC -0.393; TCGA KIRP -0.496; TCGA LUAD -0.161; TCGA LUSC -0.138; TCGA PRAD -0.411; TCGA SARC -0.185; TCGA THCA -0.196; TCGA STAD -0.129 |
hsa-miR-130a-3p | ACSL1 | 9 cancers: BLCA; CESC; HNSC; KIRP; OV; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.166; TCGA CESC -0.231; TCGA HNSC -0.246; TCGA KIRP -0.336; TCGA OV -0.371; TCGA PRAD -0.181; TCGA THCA -0.128; TCGA STAD -0.113; TCGA UCEC -0.135 |
hsa-miR-130a-3p | ASXL2 | 9 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.119; TCGA COAD -0.206; TCGA HNSC -0.504; TCGA KIRP -0.502; TCGA LUAD -0.131; TCGA LUSC -0.176; TCGA PRAD -0.4; TCGA SARC -0.168; TCGA THCA -0.273 |
hsa-miR-130a-3p | VPS13D | 10 cancers: BLCA; CESC; HNSC; KIRP; LGG; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.145; TCGA CESC -0.077; TCGA HNSC -0.245; TCGA KIRP -0.126; TCGA LGG -0.168; TCGA PRAD -0.134; TCGA SARC -0.051; TCGA THCA -0.101; TCGA STAD -0.084; TCGA UCEC -0.073 |
hsa-miR-130a-3p | ARHGEF12 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.173; TCGA COAD -0.092; TCGA ESCA -0.136; TCGA HNSC -0.233; TCGA KIRP -0.167; TCGA LUAD -0.14; TCGA PRAD -0.189; TCGA SARC -0.1; TCGA THCA -0.096; TCGA STAD -0.169; TCGA UCEC -0.062 |
hsa-miR-130a-3p | ACBD5 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.076; TCGA BRCA -0.129; TCGA CESC -0.104; TCGA COAD -0.09; TCGA ESCA -0.395; TCGA HNSC -0.13; TCGA KIRP -0.19; TCGA LGG -0.104; TCGA LUAD -0.171; TCGA LUSC -0.082; TCGA PRAD -0.207; TCGA THCA -0.091; TCGA STAD -0.187; TCGA UCEC -0.2 |
hsa-miR-130a-3p | INO80 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.071; TCGA CESC -0.061; TCGA ESCA -0.113; TCGA HNSC -0.066; TCGA KIRC -0.076; TCGA KIRP -0.078; TCGA LUAD -0.058; TCGA PRAD -0.063; TCGA SARC -0.084; TCGA STAD -0.103; TCGA UCEC -0.05 |
hsa-miR-130a-3p | SESTD1 | 11 cancers: BLCA; ESCA; HNSC; KIRP; LGG; LIHC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.218; TCGA ESCA -0.184; TCGA HNSC -0.223; TCGA KIRP -0.135; TCGA LGG -0.063; TCGA LIHC -0.15; TCGA OV -0.257; TCGA SARC -0.164; TCGA THCA -0.149; TCGA STAD -0.106; TCGA UCEC -0.167 |
hsa-miR-130a-3p | OCRL | 12 cancers: BLCA; BRCA; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.083; TCGA BRCA -0.072; TCGA HNSC -0.081; TCGA KIRP -0.144; TCGA LIHC -0.166; TCGA LUAD -0.103; TCGA PAAD -0.268; TCGA PRAD -0.142; TCGA SARC -0.139; TCGA THCA -0.086; TCGA STAD -0.17; TCGA UCEC -0.05 |
hsa-miR-130a-3p | HERC3 | 13 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.141; TCGA COAD -0.134; TCGA ESCA -0.162; TCGA HNSC -0.189; TCGA KIRC -0.116; TCGA KIRP -0.229; TCGA LUAD -0.086; TCGA OV -0.263; TCGA PRAD -0.28; TCGA SARC -0.211; TCGA THCA -0.138; TCGA STAD -0.107; TCGA UCEC -0.22 |
hsa-miR-130a-3p | SBF2 | 9 cancers: BLCA; HNSC; KIRP; LGG; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.139; TCGA HNSC -0.18; TCGA KIRP -0.149; TCGA LGG -0.108; TCGA PRAD -0.239; TCGA SARC -0.081; TCGA THCA -0.081; TCGA STAD -0.107; TCGA UCEC -0.096 |
hsa-miR-130a-3p | WDFY3 | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.127; TCGA COAD -0.093; TCGA HNSC -0.2; TCGA KIRC -0.128; TCGA KIRP -0.1; TCGA LGG -0.114; TCGA LUAD -0.071; TCGA PRAD -0.226; TCGA UCEC -0.065 |
hsa-miR-130a-3p | SLMAP | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.288; TCGA COAD -0.073; TCGA ESCA -0.175; TCGA HNSC -0.104; TCGA KIRP -0.131; TCGA LUAD -0.084; TCGA LUSC -0.083; TCGA OV -0.081; TCGA SARC -0.626; TCGA STAD -0.208; TCGA UCEC -0.152 |
hsa-miR-130a-3p | MBNL1 | 9 cancers: BLCA; COAD; HNSC; KIRC; LUSC; OV; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.138; TCGA COAD -0.066; TCGA HNSC -0.106; TCGA KIRC -0.12; TCGA LUSC -0.073; TCGA OV -0.055; TCGA SARC -0.38; TCGA STAD -0.09; TCGA UCEC -0.072 |
hsa-miR-130a-3p | PDIK1L | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LIHC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.073; TCGA BRCA -0.141; TCGA CESC -0.23; TCGA HNSC -0.121; TCGA KIRP -0.107; TCGA LIHC -0.099; TCGA PRAD -0.219; TCGA STAD -0.167; TCGA UCEC -0.103 |
hsa-miR-130a-3p | KCTD20 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.11; TCGA COAD -0.114; TCGA ESCA -0.109; TCGA HNSC -0.301; TCGA KIRP -0.245; TCGA LUAD -0.061; TCGA LUSC -0.111; TCGA PRAD -0.224; TCGA THCA -0.139; TCGA STAD -0.141; TCGA UCEC -0.076 |
hsa-miR-130a-3p | ZMAT3 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; OV; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.275; TCGA CESC -0.174; TCGA COAD -0.209; TCGA HNSC -0.472; TCGA KIRP -0.187; TCGA LUAD -0.159; TCGA LUSC -0.336; TCGA OV -0.234; TCGA THCA -0.321; TCGA STAD -0.098; TCGA UCEC -0.09 |
hsa-miR-130a-3p | PIK3C2A | 10 cancers: BLCA; COAD; ESCA; HNSC; LGG; LUAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.09; TCGA COAD -0.105; TCGA ESCA -0.1; TCGA HNSC -0.159; TCGA LGG -0.123; TCGA LUAD -0.055; TCGA PRAD -0.227; TCGA SARC -0.097; TCGA STAD -0.095; TCGA UCEC -0.057 |
hsa-miR-130a-3p | PRKAA1 | 10 cancers: BLCA; COAD; ESCA; HNSC; LUAD; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.074; TCGA COAD -0.175; TCGA ESCA -0.15; TCGA HNSC -0.082; TCGA LUAD -0.135; TCGA OV -0.127; TCGA PRAD -0.251; TCGA SARC -0.266; TCGA STAD -0.177; TCGA UCEC -0.09 |
hsa-miR-130a-3p | SPOPL | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUAD; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.088; TCGA BRCA -0.161; TCGA COAD -0.135; TCGA ESCA -0.131; TCGA KIRC -0.129; TCGA KIRP -0.099; TCGA LUAD -0.099; TCGA PRAD -0.232; TCGA SARC -0.156; TCGA THCA -0.054; TCGA STAD -0.113 |
hsa-miR-130a-3p | MIER1 | 9 cancers: BLCA; COAD; HNSC; LUAD; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.065; TCGA COAD -0.168; TCGA HNSC -0.05; TCGA LUAD -0.079; TCGA OV -0.123; TCGA PRAD -0.11; TCGA SARC -0.131; TCGA STAD -0.053; TCGA UCEC -0.073 |
hsa-miR-130a-3p | WASL | 16 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.122; TCGA CESC -0.057; TCGA COAD -0.098; TCGA ESCA -0.119; TCGA HNSC -0.109; TCGA KIRP -0.117; TCGA LGG -0.114; TCGA LIHC -0.063; TCGA LUAD -0.164; TCGA LUSC -0.122; TCGA OV -0.085; TCGA PAAD -0.156; TCGA PRAD -0.092; TCGA THCA -0.12; TCGA STAD -0.07; TCGA UCEC -0.084 |
hsa-miR-130a-3p | DENND4C | 13 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.133; TCGA COAD -0.107; TCGA ESCA -0.276; TCGA HNSC -0.219; TCGA KIRC -0.131; TCGA KIRP -0.164; TCGA LGG -0.152; TCGA LUAD -0.095; TCGA PRAD -0.208; TCGA SARC -0.112; TCGA THCA -0.083; TCGA STAD -0.159; TCGA UCEC -0.09 |
hsa-miR-130a-3p | ZNF800 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.077; TCGA CESC -0.092; TCGA COAD -0.122; TCGA ESCA -0.141; TCGA HNSC -0.19; TCGA KIRC -0.067; TCGA KIRP -0.123; TCGA LUAD -0.15; TCGA LUSC -0.14; TCGA OV -0.067; TCGA PRAD -0.183; TCGA SARC -0.087; TCGA STAD -0.133; TCGA UCEC -0.135 |
hsa-miR-130a-3p | UBE3B | 11 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.077; TCGA BRCA -0.094; TCGA HNSC -0.086; TCGA KIRC -0.066; TCGA KIRP -0.123; TCGA LIHC -0.059; TCGA LUAD -0.078; TCGA PRAD -0.082; TCGA SARC -0.166; TCGA THCA -0.077; TCGA STAD -0.068 |
hsa-miR-130a-3p | HIPK3 | 9 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.231; TCGA COAD -0.223; TCGA HNSC -0.535; TCGA KIRP -0.366; TCGA LUAD -0.154; TCGA LUSC -0.098; TCGA PRAD -0.32; TCGA SARC -0.278; TCGA STAD -0.179 |
hsa-miR-130a-3p | SKAP2 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUAD; OV; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.109; TCGA CESC -0.079; TCGA ESCA -0.135; TCGA HNSC -0.116; TCGA KIRP -0.214; TCGA LUAD -0.076; TCGA OV -0.357; TCGA PRAD -0.158; TCGA THCA -0.109; TCGA STAD -0.093; TCGA UCEC -0.133 |
hsa-miR-130a-3p | IDS | 10 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LUAD; OV; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.171; TCGA CESC -0.131; TCGA HNSC -0.154; TCGA KIRC -0.108; TCGA KIRP -0.098; TCGA LUAD -0.115; TCGA OV -0.113; TCGA SARC -0.161; TCGA THCA -0.182; TCGA STAD -0.129 |
hsa-miR-130a-3p | SEL1L | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.083; TCGA BRCA -0.07; TCGA COAD -0.15; TCGA ESCA -0.106; TCGA HNSC -0.168; TCGA KIRP -0.195; TCGA LUAD -0.116; TCGA LUSC -0.142; TCGA OV -0.125; TCGA PAAD -0.212; TCGA PRAD -0.255; TCGA SARC -0.094; TCGA THCA -0.115; TCGA UCEC -0.071 |
hsa-miR-130a-3p | MAPK1 | 14 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.05; TCGA COAD -0.075; TCGA HNSC -0.12; TCGA KIRC -0.091; TCGA KIRP -0.164; TCGA LGG -0.079; TCGA LUAD -0.102; TCGA LUSC -0.068; TCGA OV -0.13; TCGA PRAD -0.14; TCGA SARC -0.085; TCGA THCA -0.18; TCGA STAD -0.106; TCGA UCEC -0.104 |
hsa-miR-130a-3p | SPTLC2 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.051; TCGA BRCA -0.093; TCGA COAD -0.159; TCGA ESCA -0.294; TCGA HNSC -0.093; TCGA KIRP -0.128; TCGA LUAD -0.103; TCGA PRAD -0.239; TCGA THCA -0.139; TCGA STAD -0.158 |
hsa-miR-130a-3p | TRIP11 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; OV; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.102; TCGA BRCA -0.066; TCGA COAD -0.094; TCGA HNSC -0.132; TCGA KIRP -0.168; TCGA LUAD -0.069; TCGA OV -0.065; TCGA PRAD -0.288; TCGA THCA -0.099; TCGA STAD -0.098; TCGA UCEC -0.098 |
hsa-miR-130a-3p | TMX4 | 12 cancers: BLCA; COAD; HNSC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.15; TCGA COAD -0.148; TCGA HNSC -0.215; TCGA KIRP -0.188; TCGA LIHC -0.124; TCGA LUAD -0.148; TCGA OV -0.111; TCGA PAAD -0.326; TCGA PRAD -0.104; TCGA SARC -0.17; TCGA THCA -0.076; TCGA UCEC -0.222 |
hsa-miR-130a-3p | MKLN1 | 11 cancers: BLCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.074; TCGA ESCA -0.09; TCGA HNSC -0.097; TCGA KIRP -0.075; TCGA LGG -0.114; TCGA LUAD -0.109; TCGA LUSC -0.059; TCGA PRAD -0.106; TCGA SARC -0.077; TCGA STAD -0.095; TCGA UCEC -0.061 |
hsa-miR-130a-3p | CCNT1 | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; STAD | mirMAP | TCGA BLCA -0.164; TCGA COAD -0.394; TCGA HNSC -0.572; TCGA KIRC -0.194; TCGA KIRP -0.372; TCGA LUAD -0.144; TCGA LUSC -0.182; TCGA PRAD -0.482; TCGA STAD -0.069 |
hsa-miR-130a-3p | ZNF557 | 10 cancers: BLCA; CESC; COAD; KIRC; LIHC; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.054; TCGA CESC -0.125; TCGA COAD -0.098; TCGA KIRC -0.091; TCGA LIHC -0.095; TCGA LUSC -0.076; TCGA PRAD -0.072; TCGA SARC -0.079; TCGA STAD -0.071; TCGA UCEC -0.065 |
hsa-miR-130a-3p | VPS13B | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.102; TCGA BRCA -0.084; TCGA COAD -0.133; TCGA HNSC -0.141; TCGA KIRC -0.119; TCGA KIRP -0.159; TCGA LIHC -0.116; TCGA PRAD -0.313; TCGA SARC -0.074; TCGA STAD -0.134 |
hsa-miR-130a-3p | IL6ST | 10 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.331; TCGA COAD -0.347; TCGA HNSC -0.778; TCGA KIRP -0.474; TCGA LUAD -0.245; TCGA LUSC -0.229; TCGA PRAD -0.287; TCGA SARC -0.265; TCGA THCA -0.323; TCGA UCEC -0.167 |
hsa-miR-130a-3p | RAB30 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.102; TCGA BRCA -0.228; TCGA COAD -0.145; TCGA HNSC -0.251; TCGA KIRP -0.196; TCGA LGG -0.119; TCGA LUAD -0.112; TCGA LUSC -0.151; TCGA PRAD -0.289; TCGA SARC -0.22; TCGA UCEC -0.111 |
hsa-miR-130a-3p | RTF1 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.098; TCGA BRCA -0.085; TCGA COAD -0.069; TCGA HNSC -0.075; TCGA KIRP -0.063; TCGA LIHC -0.051; TCGA LUAD -0.086; TCGA PRAD -0.078; TCGA SARC -0.082; TCGA UCEC -0.072 |
hsa-miR-130a-3p | PREPL | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.122; TCGA BRCA -0.054; TCGA CESC -0.114; TCGA COAD -0.091; TCGA ESCA -0.101; TCGA HNSC -0.185; TCGA LIHC -0.062; TCGA LUAD -0.121; TCGA PAAD -0.235; TCGA PRAD -0.164; TCGA STAD -0.11; TCGA UCEC -0.055 |
hsa-miR-130a-3p | ABHD2 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.21; TCGA BRCA -0.216; TCGA CESC -0.155; TCGA ESCA -0.672; TCGA HNSC -0.357; TCGA KIRC -0.162; TCGA KIRP -0.377; TCGA LUAD -0.169; TCGA LUSC -0.24; TCGA PRAD -0.193; TCGA SARC -0.153; TCGA THCA -0.076; TCGA STAD -0.19; TCGA UCEC -0.25 |
hsa-miR-130a-3p | LPP | 10 cancers: BLCA; COAD; HNSC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.43; TCGA COAD -0.19; TCGA HNSC -0.329; TCGA LUAD -0.163; TCGA LUSC -0.105; TCGA OV -0.077; TCGA PRAD -0.218; TCGA SARC -0.633; TCGA STAD -0.149; TCGA UCEC -0.11 |
hsa-miR-130a-3p | ERLIN2 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.072; TCGA BRCA -0.138; TCGA COAD -0.123; TCGA HNSC -0.101; TCGA KIRP -0.155; TCGA LGG -0.072; TCGA LUAD -0.105; TCGA PAAD -0.128; TCGA PRAD -0.15; TCGA STAD -0.128; TCGA UCEC -0.071 |
hsa-miR-130a-3p | RAB11FIP1 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.17; TCGA BRCA -0.226; TCGA CESC -0.218; TCGA ESCA -0.679; TCGA HNSC -0.368; TCGA KIRP -0.193; TCGA LUAD -0.132; TCGA PRAD -0.159; TCGA THCA -0.288; TCGA UCEC -0.228 |
hsa-miR-130a-3p | PAFAH2 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.097; TCGA BRCA -0.158; TCGA CESC -0.126; TCGA ESCA -0.378; TCGA HNSC -0.139; TCGA KIRP -0.164; TCGA LUAD -0.159; TCGA PAAD -0.121; TCGA PRAD -0.151; TCGA THCA -0.109; TCGA UCEC -0.163 |
hsa-miR-130a-3p | TAOK1 | 10 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.174; TCGA COAD -0.252; TCGA HNSC -0.537; TCGA KIRP -0.448; TCGA LUAD -0.124; TCGA LUSC -0.191; TCGA PRAD -0.393; TCGA SARC -0.187; TCGA THCA -0.239; TCGA STAD -0.118 |
hsa-miR-130a-3p | KIAA1143 | 9 cancers: BLCA; ESCA; HNSC; LGG; LUAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.07; TCGA ESCA -0.166; TCGA HNSC -0.074; TCGA LGG -0.07; TCGA LUAD -0.052; TCGA PRAD -0.14; TCGA SARC -0.09; TCGA STAD -0.168; TCGA UCEC -0.097 |
hsa-miR-130a-3p | AR | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUSC; PRAD; SARC | mirMAP; miRNATAP | TCGA BLCA -0.614; TCGA BRCA -0.554; TCGA CESC -0.348; TCGA HNSC -1.15; TCGA KIRC -0.396; TCGA KIRP -0.376; TCGA LUSC -0.34; TCGA PRAD -0.476; TCGA SARC -0.531 |
hsa-miR-130a-3p | RASSF6 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.199; TCGA CESC -0.355; TCGA COAD -0.223; TCGA ESCA -0.758; TCGA HNSC -0.371; TCGA KIRC -0.47; TCGA KIRP -0.261; TCGA LUAD -0.183; TCGA LUSC -0.309; TCGA PRAD -0.226; TCGA STAD -0.19; TCGA UCEC -0.526 |
hsa-miR-130a-3p | NUDT4 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.22; TCGA BRCA -0.095; TCGA ESCA -0.147; TCGA HNSC -0.123; TCGA KIRP -0.125; TCGA LUAD -0.061; TCGA PRAD -0.216; TCGA THCA -0.087; TCGA STAD -0.108; TCGA UCEC -0.084 |
hsa-miR-130a-3p | GPR157 | 12 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.242; TCGA BRCA -0.129; TCGA HNSC -0.466; TCGA KIRC -0.176; TCGA KIRP -0.355; TCGA LUAD -0.165; TCGA LUSC -0.349; TCGA OV -0.19; TCGA PRAD -0.228; TCGA THCA -0.36; TCGA STAD -0.116; TCGA UCEC -0.314 |
hsa-miR-130a-3p | CYP4F3 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV | mirMAP | TCGA BLCA -0.433; TCGA BRCA -0.228; TCGA CESC -0.7; TCGA ESCA -0.552; TCGA HNSC -0.606; TCGA LGG -0.355; TCGA LUAD -0.368; TCGA LUSC -0.884; TCGA OV -0.33 |
hsa-miR-130a-3p | REPIN1 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.103; TCGA BRCA -0.169; TCGA CESC -0.093; TCGA ESCA -0.326; TCGA HNSC -0.253; TCGA KIRC -0.099; TCGA LGG -0.094; TCGA LIHC -0.163; TCGA LUSC -0.157; TCGA PRAD -0.051; TCGA SARC -0.052; TCGA THCA -0.063; TCGA UCEC -0.073 |
hsa-miR-130a-3p | CPEB4 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.271; TCGA BRCA -0.146; TCGA CESC -0.199; TCGA COAD -0.145; TCGA HNSC -0.393; TCGA KIRP -0.241; TCGA LUAD -0.142; TCGA LUSC -0.178; TCGA OV -0.244; TCGA PRAD -0.195; TCGA SARC -0.383; TCGA STAD -0.122; TCGA UCEC -0.213 |
hsa-miR-130a-3p | CNOT4 | 10 cancers: BLCA; CESC; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD | miRNATAP | TCGA BLCA -0.059; TCGA CESC -0.065; TCGA HNSC -0.122; TCGA KIRC -0.061; TCGA LGG -0.052; TCGA LIHC -0.09; TCGA LUAD -0.074; TCGA LUSC -0.094; TCGA PAAD -0.111; TCGA PRAD -0.054 |
hsa-miR-130a-3p | CHD9 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRC; LUAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.153; TCGA CESC -0.105; TCGA COAD -0.088; TCGA HNSC -0.189; TCGA KIRC -0.09; TCGA LUAD -0.096; TCGA PRAD -0.1; TCGA STAD -0.087; TCGA UCEC -0.075 |
hsa-miR-130a-3p | KLF3 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.13; TCGA CESC -0.086; TCGA COAD -0.116; TCGA ESCA -0.193; TCGA HNSC -0.12; TCGA LUAD -0.105; TCGA LUSC -0.116; TCGA PRAD -0.188; TCGA STAD -0.13; TCGA UCEC -0.066 |
hsa-miR-130a-3p | CUL3 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.095; TCGA BRCA -0.057; TCGA CESC -0.096; TCGA COAD -0.05; TCGA ESCA -0.117; TCGA HNSC -0.135; TCGA KIRP -0.075; TCGA LUAD -0.098; TCGA PAAD -0.149; TCGA PRAD -0.108; TCGA STAD -0.114 |
hsa-miR-130a-3p | G3BP2 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.055; TCGA BRCA -0.068; TCGA COAD -0.135; TCGA ESCA -0.145; TCGA HNSC -0.134; TCGA KIRP -0.18; TCGA LUAD -0.134; TCGA LUSC -0.093; TCGA PAAD -0.212; TCGA PRAD -0.234; TCGA SARC -0.099; TCGA THCA -0.103; TCGA STAD -0.081; TCGA UCEC -0.088 |
hsa-miR-130a-3p | ABCA1 | 9 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PRAD | miRNATAP | TCGA BLCA -0.095; TCGA HNSC -0.23; TCGA KIRC -0.427; TCGA KIRP -0.297; TCGA LGG -0.156; TCGA LUAD -0.096; TCGA LUSC -0.278; TCGA OV -0.163; TCGA PRAD -0.145 |
hsa-miR-130a-3p | SOS2 | 9 cancers: BLCA; COAD; HNSC; KIRP; OV; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.091; TCGA COAD -0.107; TCGA HNSC -0.142; TCGA KIRP -0.126; TCGA OV -0.078; TCGA PRAD -0.117; TCGA SARC -0.096; TCGA THCA -0.086; TCGA STAD -0.128 |
hsa-miR-130a-3p | CLCN3 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.198; TCGA BRCA -0.106; TCGA COAD -0.18; TCGA ESCA -0.161; TCGA HNSC -0.32; TCGA KIRC -0.14; TCGA KIRP -0.332; TCGA LGG -0.089; TCGA LUAD -0.135; TCGA LUSC -0.095; TCGA PAAD -0.221; TCGA PRAD -0.37; TCGA THCA -0.142; TCGA STAD -0.173; TCGA UCEC -0.121 |
hsa-miR-130a-3p | NACC2 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; OV; SARC; THCA | miRNATAP | TCGA BLCA -0.103; TCGA BRCA -0.096; TCGA ESCA -0.255; TCGA HNSC -0.123; TCGA KIRP -0.358; TCGA LGG -0.125; TCGA OV -0.133; TCGA SARC -0.406; TCGA THCA -0.261 |
hsa-miR-130a-3p | DMXL1 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.144; TCGA BRCA -0.052; TCGA CESC -0.109; TCGA COAD -0.112; TCGA HNSC -0.27; TCGA KIRC -0.152; TCGA KIRP -0.153; TCGA LUAD -0.062; TCGA OV -0.084; TCGA PRAD -0.179; TCGA SARC -0.131; TCGA THCA -0.065; TCGA STAD -0.121; TCGA UCEC -0.086 |
hsa-miR-130a-3p | TRIM2 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.385; TCGA CESC -0.33; TCGA COAD -0.134; TCGA ESCA -0.432; TCGA HNSC -0.439; TCGA LGG -0.16; TCGA LUAD -0.178; TCGA LUSC -0.17; TCGA OV -0.318; TCGA PAAD -0.241; TCGA PRAD -0.168; TCGA THCA -0.08; TCGA STAD -0.289; TCGA UCEC -0.238 |
hsa-miR-130a-3p | NFIC | 13 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.171; TCGA BRCA -0.167; TCGA HNSC -0.529; TCGA KIRC -0.107; TCGA KIRP -0.303; TCGA LIHC -0.136; TCGA LUAD -0.21; TCGA LUSC -0.211; TCGA OV -0.1; TCGA PRAD -0.224; TCGA SARC -0.349; TCGA THCA -0.168; TCGA UCEC -0.171 |
hsa-miR-130a-3p | MFSD6 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.183; TCGA BRCA -0.084; TCGA CESC -0.288; TCGA COAD -0.087; TCGA ESCA -0.31; TCGA HNSC -0.315; TCGA LGG -0.098; TCGA LUAD -0.159; TCGA LUSC -0.182; TCGA PAAD -0.292; TCGA PRAD -0.209; TCGA SARC -0.263; TCGA THCA -0.147; TCGA STAD -0.175; TCGA UCEC -0.269 |
hsa-miR-130a-3p | PIK3CB | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.055; TCGA CESC -0.117; TCGA COAD -0.057; TCGA ESCA -0.141; TCGA HNSC -0.117; TCGA KIRP -0.101; TCGA LGG -0.062; TCGA LIHC -0.056; TCGA LUAD -0.097; TCGA LUSC -0.086; TCGA PRAD -0.158; TCGA SARC -0.188; TCGA STAD -0.12; TCGA UCEC -0.116 |
hsa-miR-130a-3p | ARHGAP12 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.084; TCGA COAD -0.101; TCGA ESCA -0.467; TCGA HNSC -0.062; TCGA KIRP -0.101; TCGA LGG -0.065; TCGA LIHC -0.117; TCGA LUAD -0.157; TCGA PRAD -0.19; TCGA THCA -0.086; TCGA STAD -0.161; TCGA UCEC -0.099 |
hsa-miR-130a-3p | AKAP1 | 15 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.134; TCGA CESC -0.107; TCGA ESCA -0.471; TCGA HNSC -0.1; TCGA KIRC -0.081; TCGA KIRP -0.139; TCGA LGG -0.082; TCGA LIHC -0.067; TCGA LUAD -0.127; TCGA PAAD -0.295; TCGA PRAD -0.125; TCGA SARC -0.5; TCGA THCA -0.068; TCGA STAD -0.117; TCGA UCEC -0.117 |
hsa-miR-130a-3p | TBC1D12 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; OV; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.101; TCGA BRCA -0.083; TCGA COAD -0.079; TCGA ESCA -0.274; TCGA HNSC -0.092; TCGA LUAD -0.079; TCGA OV -0.087; TCGA PRAD -0.126; TCGA STAD -0.135; TCGA UCEC -0.113 |
hsa-miR-130a-3p | LMTK2 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.164; TCGA CESC -0.185; TCGA COAD -0.125; TCGA ESCA -0.268; TCGA HNSC -0.471; TCGA KIRC -0.261; TCGA KIRP -0.379; TCGA LUAD -0.191; TCGA LUSC -0.109; TCGA PAAD -0.247; TCGA PRAD -0.41; TCGA SARC -0.248; TCGA THCA -0.252 |
hsa-miR-130a-3p | SLC9A2 | 10 cancers: BLCA; ESCA; HNSC; KIRP; LGG; LUSC; OV; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.303; TCGA ESCA -0.928; TCGA HNSC -0.71; TCGA KIRP -0.498; TCGA LGG -0.294; TCGA LUSC -0.4; TCGA OV -0.249; TCGA PRAD -0.286; TCGA THCA -0.26; TCGA UCEC -0.223 |
hsa-miR-130a-3p | CDC73 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.058; TCGA CESC -0.082; TCGA COAD -0.152; TCGA HNSC -0.068; TCGA KIRP -0.171; TCGA LIHC -0.115; TCGA LUAD -0.075; TCGA PRAD -0.191; TCGA SARC -0.104; TCGA STAD -0.128; TCGA UCEC -0.107 |
hsa-miR-130a-3p | MID1IP1 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.126; TCGA BRCA -0.169; TCGA CESC -0.097; TCGA ESCA -0.216; TCGA HNSC -0.08; TCGA LGG -0.21; TCGA LUAD -0.146; TCGA SARC -0.203; TCGA THCA -0.144; TCGA UCEC -0.068 |
hsa-miR-130a-3p | PIK3IP1 | 9 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LUSC; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.193; TCGA HNSC -0.187; TCGA KIRC -0.162; TCGA KIRP -0.211; TCGA LGG -0.129; TCGA LUSC -0.166; TCGA SARC -0.202; TCGA THCA -0.105; TCGA UCEC -0.069 |
hsa-miR-130a-3p | REPS2 | 9 cancers: BRCA; ESCA; LGG; LUAD; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.239; TCGA ESCA -0.735; TCGA LGG -0.16; TCGA LUAD -0.221; TCGA OV -0.188; TCGA PRAD -0.221; TCGA THCA -0.244; TCGA STAD -0.234; TCGA UCEC -0.298 |
hsa-miR-130a-3p | TRIM37 | 9 cancers: BRCA; COAD; KIRP; LIHC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.085; TCGA COAD -0.063; TCGA KIRP -0.185; TCGA LIHC -0.125; TCGA PAAD -0.167; TCGA PRAD -0.169; TCGA SARC -0.068; TCGA THCA -0.126; TCGA STAD -0.116 |
hsa-miR-130a-3p | PSAP | 9 cancers: BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.093; TCGA HNSC -0.129; TCGA KIRC -0.098; TCGA KIRP -0.333; TCGA LUAD -0.064; TCGA LUSC -0.138; TCGA OV -0.102; TCGA THCA -0.288; TCGA UCEC -0.076 |
hsa-miR-130a-3p | CPPED1 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; THCA | MirTarget | TCGA BRCA -0.064; TCGA HNSC -0.181; TCGA KIRC -0.066; TCGA KIRP -0.188; TCGA LIHC -0.217; TCGA LUAD -0.12; TCGA LUSC -0.166; TCGA SARC -0.169; TCGA THCA -0.122 |
hsa-miR-130a-3p | ACBD3 | 15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.094; TCGA CESC -0.108; TCGA COAD -0.135; TCGA ESCA -0.067; TCGA HNSC -0.125; TCGA KIRP -0.19; TCGA LIHC -0.117; TCGA LUAD -0.13; TCGA LUSC -0.1; TCGA OV -0.075; TCGA PAAD -0.133; TCGA PRAD -0.221; TCGA THCA -0.062; TCGA STAD -0.077; TCGA UCEC -0.163 |
hsa-miR-130a-3p | IER3IP1 | 10 cancers: BRCA; COAD; KIRP; LIHC; LUAD; OV; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BRCA -0.094; TCGA COAD -0.121; TCGA KIRP -0.095; TCGA LIHC -0.074; TCGA LUAD -0.116; TCGA OV -0.12; TCGA PAAD -0.164; TCGA PRAD -0.119; TCGA THCA -0.062; TCGA UCEC -0.093 |
hsa-miR-130a-3p | LARP4 | 11 cancers: BRCA; COAD; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.114; TCGA COAD -0.11; TCGA HNSC -0.07; TCGA KIRP -0.175; TCGA LUAD -0.123; TCGA LUSC -0.065; TCGA PAAD -0.102; TCGA PRAD -0.206; TCGA THCA -0.148; TCGA STAD -0.128; TCGA UCEC -0.065 |
hsa-miR-130a-3p | CCDC126 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LIHC; OV; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.138; TCGA CESC -0.097; TCGA ESCA -0.121; TCGA HNSC -0.09; TCGA KIRP -0.149; TCGA LIHC -0.067; TCGA OV -0.148; TCGA PRAD -0.19; TCGA STAD -0.122; TCGA UCEC -0.105 |
hsa-miR-130a-3p | EDEM1 | 9 cancers: BRCA; COAD; HNSC; KIRC; KIRP; OV; PRAD; THCA; UCEC | MirTarget; mirMAP | TCGA BRCA -0.101; TCGA COAD -0.115; TCGA HNSC -0.084; TCGA KIRC -0.091; TCGA KIRP -0.187; TCGA OV -0.101; TCGA PRAD -0.222; TCGA THCA -0.245; TCGA UCEC -0.165 |
hsa-miR-130a-3p | SNAPIN | 9 cancers: BRCA; CESC; COAD; LIHC; LUAD; OV; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.09; TCGA CESC -0.068; TCGA COAD -0.077; TCGA LIHC -0.178; TCGA LUAD -0.072; TCGA OV -0.103; TCGA SARC -0.125; TCGA THCA -0.064; TCGA UCEC -0.059 |
hsa-miR-130a-3p | SERINC3 | 12 cancers: BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.059; TCGA ESCA -0.088; TCGA HNSC -0.082; TCGA KIRP -0.188; TCGA LUAD -0.108; TCGA LUSC -0.066; TCGA OV -0.1; TCGA PAAD -0.2; TCGA PRAD -0.184; TCGA SARC -0.137; TCGA THCA -0.137; TCGA STAD -0.094 |
hsa-miR-130a-3p | SAR1B | 15 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.201; TCGA COAD -0.129; TCGA ESCA -0.127; TCGA HNSC -0.066; TCGA KIRC -0.146; TCGA KIRP -0.244; TCGA LGG -0.105; TCGA LUAD -0.141; TCGA OV -0.173; TCGA PAAD -0.156; TCGA PRAD -0.181; TCGA SARC -0.165; TCGA THCA -0.161; TCGA STAD -0.091; TCGA UCEC -0.169 |
hsa-miR-130a-3p | TLR7 | 10 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUSC; OV; SARC; THCA | MirTarget | TCGA BRCA -0.077; TCGA CESC -0.225; TCGA COAD -0.236; TCGA HNSC -0.616; TCGA KIRC -0.463; TCGA KIRP -0.533; TCGA LUSC -0.333; TCGA OV -0.261; TCGA SARC -0.304; TCGA THCA -0.347 |
hsa-miR-130a-3p | ITPK1 | 9 cancers: BRCA; ESCA; LGG; LIHC; LUAD; OV; SARC; THCA; UCEC | MirTarget; mirMAP; miRNATAP | TCGA BRCA -0.19; TCGA ESCA -0.363; TCGA LGG -0.15; TCGA LIHC -0.065; TCGA LUAD -0.068; TCGA OV -0.097; TCGA SARC -0.256; TCGA THCA -0.062; TCGA UCEC -0.087 |
hsa-miR-130a-3p | USP32 | 10 cancers: BRCA; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.134; TCGA COAD -0.071; TCGA HNSC -0.094; TCGA KIRP -0.254; TCGA LUAD -0.135; TCGA LUSC -0.056; TCGA PRAD -0.193; TCGA SARC -0.081; TCGA THCA -0.139; TCGA STAD -0.115 |
hsa-miR-130a-3p | UBR7 | 9 cancers: BRCA; COAD; KIRP; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.105; TCGA COAD -0.09; TCGA KIRP -0.076; TCGA OV -0.072; TCGA PRAD -0.118; TCGA SARC -0.087; TCGA THCA -0.069; TCGA STAD -0.09; TCGA UCEC -0.073 |
hsa-miR-130a-3p | UBE2D2 | 10 cancers: BRCA; COAD; KIRP; LIHC; LUAD; OV; PAAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.055; TCGA COAD -0.064; TCGA KIRP -0.075; TCGA LIHC -0.07; TCGA LUAD -0.052; TCGA OV -0.07; TCGA PAAD -0.068; TCGA SARC -0.051; TCGA THCA -0.069; TCGA UCEC -0.056 |
hsa-miR-130a-3p | NIPA1 | 13 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.153; TCGA COAD -0.142; TCGA ESCA -0.17; TCGA HNSC -0.109; TCGA KIRC -0.145; TCGA KIRP -0.166; TCGA LUAD -0.107; TCGA LUSC -0.094; TCGA PRAD -0.223; TCGA SARC -0.194; TCGA THCA -0.13; TCGA STAD -0.134; TCGA UCEC -0.334 |
hsa-miR-130a-3p | CSNK1G1 | 10 cancers: BRCA; COAD; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.074; TCGA COAD -0.142; TCGA HNSC -0.06; TCGA KIRP -0.139; TCGA LIHC -0.081; TCGA LUAD -0.091; TCGA PAAD -0.106; TCGA PRAD -0.219; TCGA STAD -0.06; TCGA UCEC -0.066 |
hsa-miR-130a-3p | VPS41 | 10 cancers: BRCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.062; TCGA HNSC -0.084; TCGA KIRP -0.149; TCGA LIHC -0.079; TCGA LUAD -0.069; TCGA LUSC -0.057; TCGA PAAD -0.158; TCGA PRAD -0.092; TCGA THCA -0.175; TCGA STAD -0.087 |
hsa-miR-130a-3p | SNAP29 | 9 cancers: BRCA; KIRP; LIHC; LUAD; OV; PAAD; SARC; THCA; UCEC | mirMAP | TCGA BRCA -0.147; TCGA KIRP -0.078; TCGA LIHC -0.099; TCGA LUAD -0.061; TCGA OV -0.114; TCGA PAAD -0.095; TCGA SARC -0.123; TCGA THCA -0.061; TCGA UCEC -0.082 |
hsa-miR-130a-3p | PGK1 | 12 cancers: BRCA; COAD; KIRC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.085; TCGA COAD -0.158; TCGA KIRC -0.196; TCGA KIRP -0.33; TCGA LIHC -0.158; TCGA LUAD -0.11; TCGA OV -0.159; TCGA PAAD -0.199; TCGA PRAD -0.155; TCGA THCA -0.161; TCGA STAD -0.08; TCGA UCEC -0.125 |
hsa-miR-130a-3p | GSPT1 | 10 cancers: BRCA; COAD; KIRP; LIHC; LUAD; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.115; TCGA COAD -0.077; TCGA KIRP -0.198; TCGA LIHC -0.051; TCGA LUAD -0.115; TCGA PAAD -0.133; TCGA PRAD -0.193; TCGA THCA -0.135; TCGA STAD -0.104; TCGA UCEC -0.122 |
hsa-miR-130a-3p | MESDC2 | 10 cancers: BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; UCEC | mirMAP | TCGA BRCA -0.052; TCGA COAD -0.115; TCGA KIRC -0.087; TCGA KIRP -0.117; TCGA LGG -0.063; TCGA LIHC -0.069; TCGA LUAD -0.06; TCGA PAAD -0.159; TCGA PRAD -0.109; TCGA UCEC -0.094 |
hsa-miR-130a-3p | SRD5A3 | 12 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; THCA; UCEC | mirMAP | TCGA BRCA -0.207; TCGA CESC -0.152; TCGA ESCA -0.28; TCGA HNSC -0.119; TCGA KIRP -0.096; TCGA LIHC -0.154; TCGA LUAD -0.117; TCGA LUSC -0.112; TCGA OV -0.145; TCGA PRAD -0.098; TCGA THCA -0.106; TCGA UCEC -0.275 |
hsa-miR-130a-3p | GRSF1 | 10 cancers: BRCA; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BRCA -0.063; TCGA ESCA -0.09; TCGA KIRC -0.086; TCGA KIRP -0.16; TCGA LUAD -0.08; TCGA LUSC -0.071; TCGA PAAD -0.224; TCGA PRAD -0.123; TCGA THCA -0.106; TCGA UCEC -0.06 |
hsa-miR-130a-3p | DCAF7 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD | mirMAP | TCGA BRCA -0.05; TCGA COAD -0.065; TCGA ESCA -0.101; TCGA HNSC -0.133; TCGA KIRP -0.095; TCGA LIHC -0.091; TCGA LUAD -0.092; TCGA PAAD -0.114; TCGA PRAD -0.213 |
hsa-miR-130a-3p | KIAA1958 | 12 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.095; TCGA COAD -0.195; TCGA ESCA -0.25; TCGA HNSC -0.337; TCGA KIRC -0.149; TCGA KIRP -0.409; TCGA LUAD -0.116; TCGA PAAD -0.315; TCGA PRAD -0.354; TCGA SARC -0.179; TCGA THCA -0.137; TCGA STAD -0.149 |
hsa-miR-130a-3p | STX3 | 9 cancers: BRCA; ESCA; KIRC; KIRP; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BRCA -0.053; TCGA ESCA -0.34; TCGA KIRC -0.237; TCGA KIRP -0.16; TCGA PAAD -0.13; TCGA PRAD -0.152; TCGA SARC -0.237; TCGA THCA -0.252; TCGA UCEC -0.093 |
hsa-miR-130a-3p | DNAJC21 | 11 cancers: BRCA; KIRP; LIHC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.056; TCGA KIRP -0.191; TCGA LIHC -0.055; TCGA LUAD -0.091; TCGA OV -0.089; TCGA PAAD -0.122; TCGA PRAD -0.123; TCGA SARC -0.128; TCGA THCA -0.209; TCGA STAD -0.135; TCGA UCEC -0.053 |
hsa-miR-130a-3p | TMED10 | 9 cancers: BRCA; COAD; KIRP; LUAD; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.056; TCGA COAD -0.144; TCGA KIRP -0.147; TCGA LUAD -0.103; TCGA OV -0.092; TCGA PAAD -0.223; TCGA PRAD -0.181; TCGA STAD -0.069; TCGA UCEC -0.068 |
hsa-miR-130a-3p | YIPF6 | 16 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.147; TCGA COAD -0.124; TCGA ESCA -0.134; TCGA HNSC -0.134; TCGA KIRC -0.122; TCGA KIRP -0.405; TCGA LIHC -0.12; TCGA LUAD -0.15; TCGA LUSC -0.073; TCGA OV -0.115; TCGA PAAD -0.271; TCGA PRAD -0.329; TCGA SARC -0.137; TCGA THCA -0.215; TCGA STAD -0.117; TCGA UCEC -0.091 |
hsa-miR-130a-3p | FMN1 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.195; TCGA CESC -0.246; TCGA COAD -0.311; TCGA ESCA -0.862; TCGA HNSC -0.559; TCGA KIRP -0.6; TCGA LUAD -0.264; TCGA LUSC -0.305; TCGA PRAD -0.486; TCGA SARC -0.498; TCGA THCA -0.391; TCGA STAD -0.173; TCGA UCEC -0.164 |
hsa-miR-130a-3p | CANX | 13 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BRCA -0.067; TCGA COAD -0.143; TCGA HNSC -0.093; TCGA KIRC -0.174; TCGA KIRP -0.24; TCGA LIHC -0.149; TCGA LUAD -0.134; TCGA LUSC -0.123; TCGA OV -0.113; TCGA PAAD -0.246; TCGA PRAD -0.249; TCGA SARC -0.1; TCGA STAD -0.077 |
hsa-miR-130a-3p | TPP1 | 11 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; SARC; THCA | miRNATAP | TCGA BRCA -0.053; TCGA HNSC -0.098; TCGA KIRC -0.219; TCGA KIRP -0.316; TCGA LGG -0.08; TCGA LIHC -0.101; TCGA LUAD -0.062; TCGA LUSC -0.089; TCGA OV -0.095; TCGA SARC -0.196; TCGA THCA -0.295 |
hsa-miR-130a-3p | MLEC | 9 cancers: BRCA; ESCA; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; UCEC | miRNATAP | TCGA BRCA -0.127; TCGA ESCA -0.337; TCGA KIRC -0.268; TCGA KIRP -0.098; TCGA LIHC -0.143; TCGA LUAD -0.134; TCGA PAAD -0.266; TCGA PRAD -0.215; TCGA UCEC -0.051 |
hsa-miR-130a-3p | COX10 | 9 cancers: CESC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA CESC -0.061; TCGA KIRP -0.152; TCGA LUAD -0.083; TCGA LUSC -0.073; TCGA PAAD -0.196; TCGA PRAD -0.062; TCGA SARC -0.133; TCGA STAD -0.057; TCGA UCEC -0.067 |
hsa-miR-130a-3p | ATP11B | 9 cancers: CESC; COAD; HNSC; KIRP; LUAD; OV; PRAD; THCA; STAD | MirTarget | TCGA CESC -0.15; TCGA COAD -0.068; TCGA HNSC -0.141; TCGA KIRP -0.172; TCGA LUAD -0.064; TCGA OV -0.179; TCGA PRAD -0.34; TCGA THCA -0.131; TCGA STAD -0.136 |
hsa-miR-130a-3p | LIPA | 10 cancers: CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; THCA; UCEC | MirTarget | TCGA CESC -0.096; TCGA COAD -0.102; TCGA HNSC -0.145; TCGA KIRC -0.203; TCGA KIRP -0.336; TCGA LUAD -0.099; TCGA LUSC -0.138; TCGA OV -0.15; TCGA THCA -0.171; TCGA UCEC -0.148 |
hsa-miR-130a-3p | ATP6V1B2 | 11 cancers: CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA CESC -0.067; TCGA COAD -0.136; TCGA HNSC -0.116; TCGA KIRC -0.105; TCGA KIRP -0.191; TCGA LUAD -0.116; TCGA LUSC -0.091; TCGA OV -0.132; TCGA SARC -0.104; TCGA THCA -0.207; TCGA UCEC -0.114 |
hsa-miR-130a-3p | BTBD10 | 9 cancers: CESC; COAD; KIRP; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.078; TCGA COAD -0.069; TCGA KIRP -0.101; TCGA LUAD -0.059; TCGA PRAD -0.083; TCGA SARC -0.075; TCGA THCA -0.172; TCGA STAD -0.079; TCGA UCEC -0.06 |
hsa-miR-130a-3p | BCAP29 | 13 cancers: CESC; COAD; KIRC; KIRP; LGG; LIHC; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA CESC -0.095; TCGA COAD -0.067; TCGA KIRC -0.085; TCGA KIRP -0.086; TCGA LGG -0.081; TCGA LIHC -0.056; TCGA LUAD -0.116; TCGA OV -0.101; TCGA PAAD -0.099; TCGA PRAD -0.07; TCGA SARC -0.136; TCGA STAD -0.091; TCGA UCEC -0.134 |
hsa-miR-130a-3p | DIAPH2 | 12 cancers: CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA CESC -0.363; TCGA COAD -0.083; TCGA ESCA -0.196; TCGA HNSC -0.296; TCGA KIRP -0.18; TCGA LUAD -0.153; TCGA LUSC -0.256; TCGA PRAD -0.177; TCGA SARC -0.195; TCGA THCA -0.126; TCGA STAD -0.142; TCGA UCEC -0.117 |
hsa-miR-130a-3p | VKORC1L1 | 11 cancers: CESC; COAD; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD | mirMAP | TCGA CESC -0.055; TCGA COAD -0.079; TCGA HNSC -0.079; TCGA KIRP -0.14; TCGA LUAD -0.162; TCGA LUSC -0.107; TCGA OV -0.069; TCGA PAAD -0.268; TCGA PRAD -0.182; TCGA THCA -0.097; TCGA STAD -0.072 |
hsa-miR-130a-3p | CYLD | 9 cancers: CESC; HNSC; KIRC; KIRP; LUAD; LUSC; SARC; THCA; UCEC | miRNATAP | TCGA CESC -0.092; TCGA HNSC -0.139; TCGA KIRC -0.139; TCGA KIRP -0.075; TCGA LUAD -0.059; TCGA LUSC -0.099; TCGA SARC -0.139; TCGA THCA -0.071; TCGA UCEC -0.097 |
hsa-miR-130a-3p | RAB14 | 10 cancers: COAD; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA COAD -0.129; TCGA KIRP -0.124; TCGA LGG -0.061; TCGA LUAD -0.109; TCGA LUSC -0.067; TCGA OV -0.138; TCGA PAAD -0.097; TCGA PRAD -0.114; TCGA STAD -0.13; TCGA UCEC -0.121 |
hsa-miR-130a-3p | SLC35D1 | 9 cancers: COAD; ESCA; KIRP; LUAD; LUSC; OV; PRAD; SARC; UCEC | MirTarget | TCGA COAD -0.108; TCGA ESCA -0.236; TCGA KIRP -0.113; TCGA LUAD -0.065; TCGA LUSC -0.105; TCGA OV -0.128; TCGA PRAD -0.153; TCGA SARC -0.085; TCGA UCEC -0.055 |
hsa-miR-130a-3p | RALBP1 | 10 cancers: COAD; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA COAD -0.121; TCGA KIRP -0.111; TCGA LIHC -0.07; TCGA LUAD -0.068; TCGA LUSC -0.144; TCGA PAAD -0.122; TCGA PRAD -0.132; TCGA SARC -0.072; TCGA THCA -0.093; TCGA STAD -0.062 |
hsa-miR-130a-3p | MMGT1 | 12 cancers: COAD; HNSC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA COAD -0.133; TCGA HNSC -0.076; TCGA KIRP -0.268; TCGA LIHC -0.104; TCGA LUAD -0.114; TCGA OV -0.16; TCGA PAAD -0.222; TCGA PRAD -0.058; TCGA SARC -0.153; TCGA THCA -0.148; TCGA STAD -0.193; TCGA UCEC -0.087 |
hsa-miR-130a-3p | DSG2 | 9 cancers: COAD; ESCA; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA COAD -0.213; TCGA ESCA -0.181; TCGA KIRP -0.211; TCGA LUAD -0.112; TCGA LUSC -0.178; TCGA PAAD -0.286; TCGA PRAD -0.31; TCGA THCA -0.254; TCGA STAD -0.164 |
hsa-miR-130a-3p | RC3H2 | 9 cancers: COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA COAD -0.171; TCGA HNSC -0.271; TCGA KIRP -0.353; TCGA LUAD -0.107; TCGA LUSC -0.144; TCGA PRAD -0.273; TCGA SARC -0.076; TCGA THCA -0.121; TCGA STAD -0.144 |
hsa-miR-130a-3p | TNPO1 | 10 cancers: COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA COAD -0.114; TCGA HNSC -0.089; TCGA KIRP -0.154; TCGA LIHC -0.062; TCGA LUAD -0.089; TCGA LUSC -0.085; TCGA PAAD -0.127; TCGA PRAD -0.169; TCGA STAD -0.101; TCGA UCEC -0.073 |
hsa-miR-130a-3p | RGP1 | 11 cancers: COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA | mirMAP | TCGA COAD -0.121; TCGA ESCA -0.163; TCGA HNSC -0.41; TCGA KIRC -0.148; TCGA KIRP -0.448; TCGA LIHC -0.104; TCGA LUAD -0.112; TCGA LUSC -0.135; TCGA PRAD -0.366; TCGA SARC -0.145; TCGA THCA -0.215 |
hsa-miR-130a-3p | NUP155 | 10 cancers: COAD; HNSC; KIRC; KIRP; LIHC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA COAD -0.142; TCGA HNSC -0.1; TCGA KIRC -0.087; TCGA KIRP -0.299; TCGA LIHC -0.164; TCGA PAAD -0.174; TCGA PRAD -0.272; TCGA SARC -0.121; TCGA THCA -0.221; TCGA STAD -0.162 |
hsa-miR-130a-3p | KDSR | 9 cancers: COAD; KIRC; KIRP; LGG; LUAD; OV; SARC; THCA; STAD | mirMAP | TCGA COAD -0.144; TCGA KIRC -0.066; TCGA KIRP -0.079; TCGA LGG -0.056; TCGA LUAD -0.109; TCGA OV -0.076; TCGA SARC -0.143; TCGA THCA -0.072; TCGA STAD -0.117 |
hsa-miR-130a-3p | FGD4 | 10 cancers: COAD; ESCA; HNSC; KIRC; LGG; LUAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA COAD -0.129; TCGA ESCA -0.43; TCGA HNSC -0.207; TCGA KIRC -0.151; TCGA LGG -0.091; TCGA LUAD -0.152; TCGA PRAD -0.119; TCGA THCA -0.13; TCGA STAD -0.186; TCGA UCEC -0.105 |
hsa-miR-130a-3p | SLC30A7 | 10 cancers: COAD; ESCA; KIRC; KIRP; LUAD; LUSC; OV; PRAD; THCA; UCEC | mirMAP | TCGA COAD -0.079; TCGA ESCA -0.122; TCGA KIRC -0.108; TCGA KIRP -0.138; TCGA LUAD -0.077; TCGA LUSC -0.068; TCGA OV -0.059; TCGA PRAD -0.238; TCGA THCA -0.122; TCGA UCEC -0.082 |
hsa-miR-130a-3p | LRRC58 | 10 cancers: COAD; HNSC; KIRP; LGG; LIHC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA COAD -0.08; TCGA HNSC -0.082; TCGA KIRP -0.212; TCGA LGG -0.08; TCGA LIHC -0.11; TCGA PRAD -0.264; TCGA SARC -0.103; TCGA THCA -0.079; TCGA STAD -0.164; TCGA UCEC -0.074 |
hsa-miR-130a-3p | LIN54 | 10 cancers: COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD | mirMAP | TCGA COAD -0.128; TCGA HNSC -0.115; TCGA KIRC -0.13; TCGA KIRP -0.119; TCGA LUAD -0.076; TCGA LUSC -0.067; TCGA OV -0.092; TCGA PAAD -0.1; TCGA PRAD -0.17; TCGA STAD -0.132 |
hsa-miR-130a-3p | MBP | 12 cancers: COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA COAD -0.183; TCGA ESCA -0.125; TCGA HNSC -0.232; TCGA KIRP -0.274; TCGA LUAD -0.194; TCGA LUSC -0.135; TCGA OV -0.109; TCGA PRAD -0.144; TCGA SARC -0.336; TCGA THCA -0.115; TCGA STAD -0.086; TCGA UCEC -0.149 |
hsa-miR-130a-3p | ZFP91 | 11 cancers: COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA COAD -0.137; TCGA HNSC -0.089; TCGA KIRC -0.076; TCGA KIRP -0.211; TCGA LUAD -0.086; TCGA LUSC -0.064; TCGA PRAD -0.186; TCGA SARC -0.105; TCGA THCA -0.164; TCGA STAD -0.092; TCGA UCEC -0.088 |
hsa-miR-130a-3p | SLC44A1 | 9 cancers: ESCA; KIRP; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA ESCA -0.102; TCGA KIRP -0.195; TCGA LUAD -0.148; TCGA LUSC -0.19; TCGA OV -0.129; TCGA PRAD -0.103; TCGA THCA -0.123; TCGA STAD -0.109; TCGA UCEC -0.186 |
hsa-miR-130a-3p | SEL1L3 | 9 cancers: ESCA; HNSC; KIRC; LUAD; LUSC; OV; PRAD; THCA; UCEC | MirTarget | TCGA ESCA -0.597; TCGA HNSC -0.242; TCGA KIRC -0.263; TCGA LUAD -0.207; TCGA LUSC -0.263; TCGA OV -0.181; TCGA PRAD -0.249; TCGA THCA -0.26; TCGA UCEC -0.193 |
hsa-miR-130a-3p | ARHGAP21 | 9 cancers: ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA ESCA -0.127; TCGA HNSC -0.074; TCGA KIRC -0.074; TCGA KIRP -0.139; TCGA LUAD -0.075; TCGA LUSC -0.092; TCGA PRAD -0.092; TCGA SARC -0.166; TCGA STAD -0.095 |
hsa-miR-130a-3p | RNF125 | 9 cancers: ESCA; HNSC; KIRP; LUAD; OV; PRAD; THCA; STAD; UCEC | mirMAP | TCGA ESCA -0.42; TCGA HNSC -0.361; TCGA KIRP -0.197; TCGA LUAD -0.1; TCGA OV -0.149; TCGA PRAD -0.093; TCGA THCA -0.161; TCGA STAD -0.144; TCGA UCEC -0.194 |
hsa-miR-130a-3p | FKTN | 10 cancers: ESCA; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA ESCA -0.13; TCGA KIRC -0.1; TCGA KIRP -0.075; TCGA LGG -0.074; TCGA LIHC -0.073; TCGA LUAD -0.065; TCGA PAAD -0.163; TCGA PRAD -0.184; TCGA STAD -0.181; TCGA UCEC -0.069 |
hsa-miR-130a-3p | KLF13 | 9 cancers: ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA | miRNATAP | TCGA ESCA -0.136; TCGA HNSC -0.173; TCGA KIRP -0.119; TCGA LIHC -0.131; TCGA LUAD -0.087; TCGA LUSC -0.207; TCGA PRAD -0.116; TCGA SARC -0.082; TCGA THCA -0.073 |
hsa-miR-130a-3p | PLAA | 11 cancers: HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA HNSC -0.072; TCGA KIRP -0.225; TCGA LGG -0.061; TCGA LIHC -0.059; TCGA LUAD -0.05; TCGA LUSC -0.134; TCGA PAAD -0.103; TCGA PRAD -0.137; TCGA THCA -0.104; TCGA STAD -0.115; TCGA UCEC -0.055 |
hsa-miR-130a-3p | LAMP2 | 11 cancers: HNSC; KIRC; KIRP; LGG; LIHC; LUAD; OV; PRAD; THCA; STAD; UCEC | mirMAP | TCGA HNSC -0.117; TCGA KIRC -0.125; TCGA KIRP -0.358; TCGA LGG -0.096; TCGA LIHC -0.075; TCGA LUAD -0.076; TCGA OV -0.098; TCGA PRAD -0.175; TCGA THCA -0.247; TCGA STAD -0.102; TCGA UCEC -0.17 |
hsa-miR-130a-3p | GCLM | 9 cancers: HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; THCA; UCEC | mirMAP | TCGA HNSC -0.268; TCGA KIRP -0.441; TCGA LIHC -0.111; TCGA LUAD -0.205; TCGA LUSC -0.322; TCGA OV -0.112; TCGA PRAD -0.235; TCGA THCA -0.114; TCGA UCEC -0.138 |
Enriched cancer pathways of putative targets